Date
- Tuesday, 23 November 2021, All day
Location
- OnlineEuropean Medicines Agency, Amsterdam, the Netherlands
Event summary
This is the seventh in a series of regular meetings between regulators and representatives of industry stakeholder organisations. It addresses all areas of evidence generation along the medicine’s life-cycle and related product-development support activities, such as scientific advice and qualification, as well as specifics for paediatric and orphan medicines.
This meeting will focus on various activities contributing to renovating the scientific advice offering, review of the experience with the PRIME scheme, progressing the integration of Real World Evidence into medicines development and considerations regarding the concept of an ‘evolutionary’ paediatric investigation plan.